Results 101 to 110 of about 234,526 (262)

Associations between TMEM106B C‐terminal fragment aggregation, age, and TDP‐43 or tau pathology

open access: yesBrain Pathology, EarlyView.
TMEM106B C‐terminal fragment (CTF) aggregation represents an age‐associated, common, diffuse phenomenon emerging after midlife with a weak association with TDP‐43 or tau pathology. These findings suggest that TMEM106B fibrillization may define a distinct axis of protein aggregation in the aging human brain. Abstract Transmembrane protein 106B (TMEM106B)
Albert Acewicz   +5 more
wiley   +1 more source

Seropositivity Status in Patients with Suspected Measles: Are We Going Back to The Beginning with Measles?

open access: yesEurasian Journal of Medicine
Background: Measles is a highly contagious viral infection that can cause serious health problems. While measles can be eradicated through vaccination in our country and worldwide, in recent years, vaccine refusal, difficulties in accessing vaccines ...
Çiğdem Eda Balkan Bozlak   +3 more
doaj   +1 more source

Low titers of measles antibody in mothers whose infants suffered from measles before eligible age for measles vaccination

open access: yesVirology Journal, 2010
Background Resurgence or outbreak of measles recently occurred in both developed and developing countries despite long-standing widespread use of measles vaccine. Measles incidence in China has increased since 2002, particularly in infants and in persons
Wu Qiaozhen   +5 more
doaj   +1 more source

Measles Vaccine [PDF]

open access: yesViral Immunology, 2018
Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was developed empirically by attenuation of wild-type (WT) MeV by in vitro passage in human and chicken cells and licensed in 1963.
openaire   +2 more sources

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu   +6 more
wiley   +1 more source

Measles vaccination – An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germany

open access: yesInternational Journal of Medical Microbiology
Measles and rubella are targeted for elimination in the WHO region Europe. To reach the elimination goal, vaccination coverage of 95% must be achieved and sustained, the genotype information has to be provided for 80% of all outbreaks and transmission ...
Katharina Hueppe   +4 more
doaj   +1 more source

On Racialized, Gendered, Precarious Work: Struggles of Community Health Workers During the National Health Insurance Pilot Program in the Tshwane District, South Africa

open access: yesGender, Work &Organization, EarlyView.
ABSTRACT The infrastructure of precarious work is racialized and gendered, affecting disenfranchised Black women who carry the burden of low paid caregiving within the healthcare system. In South Africa, Community Health Workers, predominantly Black women from marginalized communities, have been vital in providing primary healthcare services at home ...
Sivuyisiwe Wonci
wiley   +1 more source

Last Year\u27s Virus, This Year\u27s Cancer Treatment [PDF]

open access: yes, 2018
For hundreds of years, cancer has stumped medical professionals across the world as a cure evaded them. Now, a new approach to battling cancer has entered the arena: viruses.
Collins, Olivia
core   +1 more source

Measles [PDF]

open access: yesCanadian Medical Association Journal, 2014
Derek R, MacFadden, Wayne L, Gold
openaire   +2 more sources

Perspectives on Pertussis Prevention

open access: yes
Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Home - About - Disclaimer - Privacy